API China
April 23, 2026
Source: drugdu
33
Organiser：Sinopharm Holdings Reed Exhibition
Time： May 13 - May 15, 2026
Address：No. 333 Songze Avenue, Xujing Town, Qingpu District, Shanghai
Exhibition hall：National Exhibition and Convention Center (Shanghai)
Product range:
Pharmaceutical active pharmaceutical ingredients (APIs), pharmaceutical excipients, natural extracts, chemical reagents, intermediates, fine chemical raw materials, Chinese medicinal raw materials, food raw materials and additives, veterinary drug raw materials, feed raw materials and additives, health supplement raw materials and additives, biotechnology, pharmaceutical research and development services, contract custom manufacturing services, registration and pharmaceutical affairs services, training services
About API China：
China International Pharmaceutical API Expo (API China), as the longest-established exhibition in China's pharmaceutical sector, was initiated in 1968. The exhibits not only encompass over 24 major categories with more than 50,000 types of APIs but also include all excipients, functional ingredients, internal and external packaging materials, as well as production and testing equipment required for the manufacturing of pharmaceuticals and health supplements. With the ongoing implementation of the consistency evaluation for generic drugs and the policy promoting the joint review and approval of APIs, excipients, and packaging materials, pharmaceutical companies are now more proactive in enhancing product quality and taking responsibility for their own products, which has also significantly boosted the initiative of API enterprises.
Copyright©2026 Ddu. All rights reserved.
Read more on
- The Guangzhou International Medical Devices Exhibition April 21, 2026
- The Shanxi Medical Device Exhibition (CWMEE) April 16, 2026
- PHARMCHINA April 14, 2026
- PHARMPACK April 9, 2026
- SINOPHEX SHANGHAI April 7, 2026
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
